Condensed Consolidated Balance Sheets - USD ($)	Jan. 31, 2022	Apr. 30, 2021
Current assets
Cash and cash equivalents	$ 1,082,446	$ 928,796
Accounts receivable, net	1,209,253	762,487
Inventories, net	8,669,721	3,693,216
Prepaid inventory	1,777,905	140,047
Loan and interest receivable	2,355,349
Prepaid expenses and other current assets	99,785	60,113
Total current assets	15,194,459	5,584,659
Goodwill	1,240,000
Other intangible assets, net	2,200,105	112,853
Total assets	18,634,564	5,697,512
Current liabilities
Accounts payable and accrued expenses	7,942,523	2,050,476
Accrued payroll and bonuses	1,612,531	1,283,464
Deferred revenue	18,508	99,531
Accrued interest - related party	850,092	747,636
Notes payable - related party, net	2,000,000	6,143,223
Convertible notes payable, net	7,577,778
Derivative liabilities	8,926,083	13,813,449
Total current liabilities	28,927,515	24,137,779
Long-term liabilities
Note payable, net		10,477
Total liabilities	28,927,515	24,148,256
Commitments and contingencies (Note 11)
Shareholders’ deficit
Common stock, $0.001 par value, 300,000,000 shares authorized, 41,888,372 and 27,642,828 shares issued and outstanding as of January 31, 2022 (unaudited) and April 30, 2021, respectively; 0 and 6,921,299 shares issuable as of January 31, 2022 (unaudited) and April 30, 2021, respectively	41,888	27,643
Additional paid-in capital	63,166,203	10,365,056
Accumulated other comprehensive loss	(46,976)	(20,170)
Accumulated deficit	(73,454,066)	(28,823,273)
Total shareholders’ deficit	(10,292,951)	(18,450,744)
Total liabilities and shareholders’ deficit	$ 18,634,564	$ 5,697,512